# Bridge Study to Evaluate the Efficacy and Safety of IN-B00009 Injection in Patients With T2DM Inadequately Controlled by Diet and Exercise Alone

> **NCT07308184** · PHASE3 · NOT_YET_RECRUITING · sponsor: **HK inno.N Corporation** · enrollment: 110 (estimated)

## Conditions studied

- Diabetes (DM)
- Diabetes Mellitus Type 2

## Interventions

- **DRUG:** IN-B00009
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07308184
- **Lead sponsor:** HK inno.N Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12
- **Primary completion:** 2027-08
- **Final completion:** 2027-09
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2025-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07308184

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07308184, "Bridge Study to Evaluate the Efficacy and Safety of IN-B00009 Injection in Patients With T2DM Inadequately Controlled by Diet and Exercise Alone". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07308184. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*